Feasibility and acceptability of pulmonary rehabilitation for people with chronic lung diseases in Malawi

ISRCTN	ISRCTN13836793
DOI	https://doi.org/10.1186/ISRCTN13836793
Secondary identifying numbers	P.07/19/2752, WT 221465/Z/20/Z

Submission date: 20/08/2021
Registration date: 27/08/2021
Last edited: 23/05/2025

Recruitment status: No longer recruiting
Overall study status: Completed
Condition category: Respiratory

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Plain English summary of protocol

Background and study aims
Malawi has a substantial burden of chronic respiratory diseases (CRDs) which cause significant deaths and loss of economic productivity, affecting patients, families, and health systems alike. Pulmonary rehabilitation (PR) is a highly recommended non-drug intervention in the clinical management of people with CRDs. However, Malawi lacks published evidence on the implementation of PR for people with CRDs. This trial will test the feasibility and acceptability of a culturally appropriate hospital-based PR programme among adults with functionally limiting CRDs at Queen Elizabeth Central Hospital in Blantyre, Malawi.

Who can participate?
Both male and female adults (aged 18 years or older) with spirometry confirmed diagnosis of chronic respiratory disease (CRD) and functional limitation due to breathlessness reaching a score of ≥2 on the modified Medical Research Council (mMRC) dyspnoea scale

What does the study involve?
Eligible study participants will participate in a six-week, twice-weekly, supervised hospital-based pulmonary rehabilitation (PR) programme, with an additional weekly home-based non-supervised session. Assessment of participants' lung function, exercise tolerance, and health status will be conducted at both baseline (week 0) and end of the PR programme (week 6). In addition, semi-structured in-depth interviews with participants will be conducted before and after their participation in the PR programme.

What are the possible benefits and risks of participating?
Participation will help inform the design of a culturally appropriate pulmonary rehabilitation (PR) programme for people with chronic lung diseases (CRDs) in Malawi. Risks from participation are not anticipated.

Where is the study run from?
Malawi-Liverpool-Wellcome Trust Clinical Research Programme (Malawi)

When is the study starting and how long is it expected to run for?
September 2018 to December 2021

Who is funding the study?
1. National Institute for Health Research (NIHR) (UK)
2. Wellcome Trust (UK) [221465/Z/20/Z]
3. Royal Society of Tropical Medicine & Hygiene (RSTMH) (UK)
4. Academy of Medical Sciences Global Challenges Research Fund (GCRF) Networking Grant Scheme (GCRFNGR5\1242)
4. NIHR- Global Health Research Group on Respiratory Rehabilitation (Global RECHARGE) (17/63/20) using UK aid from the UK Government to support global health research

Who is the main contact?
Mr. Fanuel Meckson Bickton (fbickton@mlw.mw)

Study website

Contact information

Mr Fanuel Bickton
Public

Malawi-Liverpool-Wellcome Trust Clinical Research Programme
P.O Box 30096
Blantyre
-
Malawi

ORCID ID	0000-0002-0925-909X
Phone	+265 882 63 06 94
Email	fbickton@mlw.mw

Mr Fanuel Bickton
Scientific

Malawi-Liverpool-Wellcome Trust Clinical Research Programme
P.O Box 30096
Blantyre
-
Malawi

Phone	+265 882 63 06 94
Email	fbickton@mlw.mw

Study information

Study design	Single-centre mixed-methods pre-post single-arm feasibility trial
Primary study design	Observational
Secondary study design	Cohort study
Study setting(s)	Hospital
Study type	Treatment
Participant information sheet	Not available in web format, please use contact details to request a participant information sheet
Scientific title	Protocol for a single-centre mixed-methods pre-post single-arm feasibility trial of a culturally appropriate six-week pulmonary rehabilitation programme among adults with functionally limiting chronic respiratory diseases in Malawi
Study objectives	1. To co-design, with service users and stakeholders, a locally appropriate pulmonary rehabilitation programme for adult patients with functionally limiting chronic respiratory diseases in Malawi. 2. To examine participants’ recruitment, retention, engagement, adverse events, drop-outs, loss to follow up, and patient acceptability. 3. To describe changes in lung function, exercise capacity and health status of participants after completing the PR programme.
Ethics approval(s)	1. Approved 08/09/2019, University of Malawi College of Medicine Research and Ethics Committee (Mahatma Gandhi Road, Chimutu Building Room # 822, P/Bag 360 Chichiri, Blantyre 3, Malawi; +265) 01 871 911; comrec@medcol.mw), ref: P.07/19/2752 2. Approved 20/07/2021, University of Leicester Ethics Committee (The University of Leicester, University Road, Leicester, LE1 7RH, United Kingdom; +44 (0)1162522522; ethicsapp@leicester.ac.uk), ref: 31574
Health condition(s) or problem(s) studied	Adults with functionally limiting chronic respiratory diseases in Malawi
Intervention	This is a single-centre mixed-methods pre-post single-arm feasibility trial of a culturally appropriate six-week pulmonary rehabilitation (PR) programme among adults with functionally limiting chronic respiratory diseases (CRDs) in Malawi. Twenty-five patients ≥18 years old, with a spirometry confirmed diagnosis of a chronic respiratory disease and breathlessness of ≥2 on the modified Medical Research Council dyspnoea scale, will be consecutively recruited at Queen Elizabeth Central Hospital (QECH). Their baseline lung function, exercise tolerance, and health status will be assessed using spirometry, incremental shuttle walk test and chronic obstructive pulmonary disease assessment test, respectively. Semi-structured in-depth interviews will explore their experiences of living with CRD and potential enablers and barriers to their PR uptake. Along with international PR guidelines, these data will inform culturally appropriate delivery of PR. We initially propose a six-week, twice-weekly, supervised centre-based PR programme, with an additional weekly home-based non-supervised session. Following programme completion (after six weeks), repeat assessments of lung function, exercise tolerance and health status will be conducted. Quantitative changes in clinical outcomes will be discussed in relation to published minimal clinically important differences. Follow-up semi-structured interviews will capture participants’ perceived impact of the PR programme on their quality of life, enablers, and barriers to fully engaging with the programme, and allow iteration of its design.
Intervention type	Behavioural
Primary outcome measure	1. Input for a culturally appropriate pulmonary rehabilitation (PR) programme collected through semi-structured in-depth interviews at baseline (at week 0) 2. Participants' acceptability of the PR programme explored through semi-structured in-depth interviews at the end of the programme duration (at week 6)
Secondary outcome measures	1. Lung function (pre- and post-bronchodilator forced expiratory volume in one second (FEV1), forced vital capacity (FVC) and FEV1/FVC ratio) measured using spirometry at both baseline (at week 0) and end of the trial (at week 6) 2. Health status variables such as participants’ perceived respiratory disability due to dyspnoea (using the modified Medical Research Council (mMRC) dyspnoea scale), health-related quality of life (using the chronic obstructive pulmonary disease assessment test (CAT)), subjective experience of fatigue (using the Checklist Individual Strength fatigue subscale (CIS-Fatigue)), and emotional health (using the Hospital Anxiety and Depression Scale (HADS)), at both baseline (at week 0) and end of the trial (at week 6) 3. Physical fitness variables such as exercise tolerance (using the incremental shuttle walk test (ISWT)), lower extremity muscular strength using five-repetition sit-to-stand test (5XSST) and hamstring flexibility measured using the chair sit-and-reach (CSR) test, at both baseline (at week 0) and end of the trial (at week 6)
Overall study start date	19/09/2018
Completion date	31/12/2021

Eligibility

Participant type(s)	Patient
Age group	Adult
Lower age limit	18 Years
Sex	Both
Target number of participants	25
Total final enrolment	10
Key inclusion criteria	1. Those aged 18 years or older 2. Those with a spirometry confirmed diagnosis of chronic respiratory disease (CRD) 3. Those with functional limitation due to breathlessness reaching a score of ≥2 on the modified Medical Research Council (mMRC) dyspnoea scale
Key exclusion criteria	1. Those with significant cardiovascular, neurological, orthopaedic, cognitive, or any other condition that would compromise participation in the rehabilitation programme 2. Those with an active infection including tuberculosis (TB) and coronavirus disease 2019 (COVID-19) 3. Those with respiratory disease which is thought primarily to originate from recent COVID-19 infection 4. Those unable to provide informed consent
Date of first enrolment	01/10/2021
Date of final enrolment	31/10/2021

Locations

Countries of recruitment

Malawi

Study participating centre

Queen Elizabeth Central Hospital

Blantyre
Post Office Box 95
Malawi

Sponsor information

University of Leicester
University/education

University road
Leicester
LE17RH
England
United Kingdom

Phone	+44 (0) 1162522522
Email	smd8@leicester.ac.uk
Website	http://www.le.ac.uk
"ROR"	https://ror.org/04h699437

Funders

Funder type

Charity

Wellcome Trust
Private sector organisation / Trusts, charities, foundations (both public and private)

Alternative name(s): Wellcome, WT
Location: United Kingdom

National Institute for Health Research
Government organisation / National government

Alternative name(s): National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
Location: United Kingdom

Academy of Medical Sciences
Private sector organisation / Other non-profit organizations

Alternative name(s): The Academy of Medical Sciences
Location: United Kingdom

Royal Society of Tropical Medicine and Hygiene
Private sector organisation / Associations and societies (private and public)

Alternative name(s): RSTMH
Location: United Kingdom

Results and Publications

Intention to publish date	31/03/2022
Individual participant data (IPD) Intention to share	Yes
IPD sharing plan summary	Stored in publicly available repository
Publication and dissemination plan	The results of the trial will be disseminated through oral presentations at local and international scientific conferences or seminars and publication in a peer-reviewed journal. We will also engage the participants who complete the PR trial and the Science Communication Department at Malawi-Liverpool-Wellcome Trust Clinical Research Programme to organise community outreach activities within Blantyre to educate communities about CRDs and PR. We will also broadcast our trial results through national radio station programmes such as the weekly “Thanzi la Onse” (Health of All) programme by Times Radio Malawi. We will formally present our trial results to Blantyre District Health Office and Malawi Ministry of Health.
IPD sharing plan	Anonymized datasets generated and/or analyzed during the current study will be stored/published in a publicly available database and repository. The case report forms (CRFs) for the study will be printed out so that participants’ data collected by these will be stored in physical form. All CRFs with participants’ data will be stored securely in a locked cabinet in the Physiotherapy Department at Queen Elizabeth Central Hospital. These will later be anonymized and digitally archived on a public online database similar to IMPALA’s peer-reviewed ‘Questionnaires for Lung Health across the Life Course’ (https://github.com/jipp3r/IMPALA_QuestionSet), as a harmonized and shared data collection system of demographics, baseline, and pulmonary rehabilitation (PR) outcomes for patients undergoing PR in Malawi. The management of the system will be supported by the Data Management Support Unit at the Malawi-Liverpool-Wellcome Trust Clinical Research Programme. Likewise, interview data will be anonymized at the time of translation and transcription (e.g, participants’ identifiers such as names will be removed). All anonymized transcripts will be stored in a publicly available repository (https://doi.org/10.6084/m9.figshare.19165667).

Study outputs

Output type	Date created	Date added	Peer reviewed?	Patient-facing?
Preprint results		05/10/2022	No	No
Protocol article	31/01/2022	05/10/2022	Yes	No
Dataset	13/02/2022	10/02/2023	No	No
Results article	22/05/2025	23/05/2025	Yes	No

Editorial Notes

23/05/2025: Publication reference added.
10/02/2023: IPD sharing statement, dataset and total final enrolment added.
05/10/2022: Publication references added.
23/08/2021: Trial's existence confirmed by University of Leicester